Acurx Pharmaceuticals to Present at the Emerging Growth Conference on January 25, 2023

Rhea-AI Summary

Acurx Pharmaceuticals (NASDAQ: ACXP) has announced its participation in the Emerging Growth Conference on January 25, 2023. The event will feature a live, interactive session with President & CEO David P. Luci, allowing shareholders and the investment community to engage directly. The session is scheduled from 9:40 am to 10:10 am Eastern Time. Attendees can submit questions beforehand or ask live during the event. An archived version will be available post-event on EmergingGrowth.com. Acurx focuses on developing innovative antibiotics targeting challenging bacterial infections.

Acurx invites individual and institutional investors, financial advisors and analysts to attend its real-time, interactive question and answer session at the Emerging Growth Conference

STATEN ISLAND, N.Y., Jan. 16, 2023  /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, is pleased to announce that it has been invited to present at the Emerging Growth Conference on January 25, 2023.  This live, interactive online event will provide existing stockholders and the investment community with the opportunity to interact with the Company's President & Chief Executive Officer, David P. Luci, in real time. Mr. Luci will conduct an interview and open the floor for questions. Please submit your questions in advance to Questions@EmergingGrowth.com or ask your questions during the event and Mr. Luci will do his best to respond to as many as possible.

Details of this event are as follows:

Date:	Wednesday, January 25, 2023
Time:	9:40 am to 10:10 am Eastern Time
Webcast:	https://goto.webcasts.com/starthere.jsp?ei=1575092&tp_key=9111d280ed&sti=acxp

This live, interactive online event will provide current stockholders and the investment community the opportunity to interact with David P. Luci. As time permits, Mr. Luci may be able to respond to questions from participants.

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, http://www.YouTube.com/EmergingGrowthConference. We will release a link to that after the event.

About the Emerging Growth Conference

The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.

The Conference focus and coverage includes companies in a wide range of growth sectors with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.

All sessions will be conducted through video webcasts and will take place in the Eastern time zone.

About Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing an entirely new class of antibiotics for difficult to treat infections. The Company's approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme and its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin resistant Enterococcus (VRE) and drug-resistant Streptococcus pneumoniae (DRSP). To learn more about Acurx Pharmaceuticals and its product pipeline, please visit www.acurxpharma.com 

Forward-Looking Statements

Any statements in this press release about our future expectations, plans and prospects, including statements regarding our strategy, future operations, prospects, plans and objectives, and other statements containing the words "believes," "anticipates," "plans," "expects," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: whether ibezapolstat will benefit from the QIDP designation; whether ibezapolstat will advance through the clinical trial process on a timely basis; whether the results of the clinical trials of ibezapolstat will warrant the submission of applications for marketing approval, and if so, whether ibezapolstat will receive approval from the FDA or equivalent foreign regulatory agencies where approval is sought; whether, if ibezapolstat obtains approval, it will be successfully distributed and marketed; and other risks and uncertainties described in the Company's annual report filed with the Securities and Exchange Commission on Form 10-K for the year ended December 31, 2021, and in the Company's subsequent filings with the Securities and Exchange Commission. Such forward-looking statements speak only as of the date of this press release, and Acurx disclaims any intent or obligation to update these forward-looking statements to reflect events or circumstances after the date of such statements, except as may be required by law.

Investor Contact:
Acurx Pharmaceuticals, Inc.
David P. Luci, President & CEO
Tel:  917-533-1469
Email:  davidluci@acurxpharma.com

View original content:https://www.prnewswire.com/news-releases/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-january-25-2023-301721887.html

SOURCE Acurx Pharmaceuticals, Inc.

FAQ

What is Acurx Pharmaceuticals presenting at the Emerging Growth Conference?

Acurx Pharmaceuticals will present its developments in antibiotic therapies at the Emerging Growth Conference on January 25, 2023.

When is the Emerging Growth Conference for Acurx Pharmaceuticals?

The Emerging Growth Conference for Acurx Pharmaceuticals is scheduled for January 25, 2023.

What time will Acurx Pharmaceuticals present at the conference?

Acurx Pharmaceuticals' presentation at the conference will take place from 9:40 am to 10:10 am Eastern Time.

Who is the CEO of Acurx Pharmaceuticals participating in the conference?

The CEO of Acurx Pharmaceuticals participating in the conference is David P. Luci.

How can I submit questions for the Acurx Pharmaceuticals conference?

Questions for Acurx Pharmaceuticals' conference can be submitted in advance via email to Questions@EmergingGrowth.com.

Where can I watch the Acurx Pharmaceuticals conference after it happens?

The archived webcast of the Acurx Pharmaceuticals conference will be available on EmergingGrowth.com and its YouTube channel after the event.